药物对比
Ergotamine vs Lasmiditan
麦角胺收缩血管但有心脏风险黑框警告，而拉米地坦是5-HT1F激动剂，无血管收缩作用。
此页面暂无可用的对比维度。
临床背景
Patients with acute migraine and cardiovascular risk factors compare Ergotamine vs Lasmiditan for treatment.
结论
Lasmiditan is generally safer than Ergotamine due to its non-vasoconstrictive mechanism and lack of black box warning.
全部药物对比